PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RxSight, Inc. (RXST)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US78349D1072

CUSIP

78349D107

Sector

Healthcare

IPO Date

Jul 30, 2021

Highlights

Market Cap

$1.53B

EPS (TTM)

-$0.81

Total Revenue (TTM)

$138.39M

Gross Profit (TTM)

$87.81M

EBITDA (TTM)

-$26.47M

Year Range

$34.92 - $66.54

Target Price

$60.50

Short %

6.72%

Short Ratio

3.95

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
RXST vs. TRML RXST vs. ACIC RXST vs. ALPN RXST vs. MMYT RXST vs. SLNO RXST vs. TRAK RXST vs. IDYA RXST vs. APO RXST vs. VRT RXST vs. SOXX
Popular comparisons:
RXST vs. TRML RXST vs. ACIC RXST vs. ALPN RXST vs. MMYT RXST vs. SLNO RXST vs. TRAK RXST vs. IDYA RXST vs. APO RXST vs. VRT RXST vs. SOXX

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in RxSight, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%50.00%100.00%150.00%200.00%250.00%JulyAugustSeptemberOctoberNovemberDecember
110.37%
34.94%
RXST (RxSight, Inc.)
Benchmark (^GSPC)

Returns By Period

RxSight, Inc. had a return of -16.52% year-to-date (YTD) and -13.25% in the last 12 months.


RXST

YTD

-16.52%

1M

-24.88%

6M

-40.68%

1Y

-13.25%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

24.34%

1M

0.23%

6M

8.53%

1Y

24.95%

5Y*

13.01%

10Y*

11.06%

Monthly Returns

The table below presents the monthly returns of RXST, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202412.87%19.91%-5.48%1.07%12.16%2.91%-23.93%23.20%-12.34%2.49%-7.46%-16.52%
202310.50%-2.00%21.57%7.31%36.15%18.18%15.87%-13.07%-3.86%-20.62%36.22%33.69%218.23%
2022-8.53%30.42%-7.75%-0.89%11.33%3.07%6.25%-16.38%-4.08%3.67%2.65%-0.78%12.62%
2021-3.87%-17.62%-5.45%-9.43%3.69%-29.69%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of RXST is 36, indicating average performance compared to other stocks on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of RXST is 3636
Overall Rank
The Sharpe Ratio Rank of RXST is 3737
Sharpe Ratio Rank
The Sortino Ratio Rank of RXST is 3636
Sortino Ratio Rank
The Omega Ratio Rank of RXST is 3636
Omega Ratio Rank
The Calmar Ratio Rank of RXST is 3333
Calmar Ratio Rank
The Martin Ratio Rank of RXST is 3636
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for RxSight, Inc. (RXST) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for RXST, currently valued at -0.22, compared to the broader market-4.00-2.000.002.00-0.222.10
The chart of Sortino ratio for RXST, currently valued at 0.05, compared to the broader market-4.00-2.000.002.004.000.052.80
The chart of Omega ratio for RXST, currently valued at 1.01, compared to the broader market0.501.001.502.001.011.39
The chart of Calmar ratio for RXST, currently valued at -0.25, compared to the broader market0.002.004.006.00-0.253.09
The chart of Martin ratio for RXST, currently valued at -0.63, compared to the broader market-5.000.005.0010.0015.0020.0025.00-0.6313.49
RXST
^GSPC

The current RxSight, Inc. Sharpe ratio is -0.22. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of RxSight, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.22
2.10
RXST (RxSight, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


RxSight, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-47.64%
-2.62%
RXST (RxSight, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the RxSight, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the RxSight, Inc. was 48.21%, occurring on Jan 7, 2022. Recovery took 316 trading sessions.

The current RxSight, Inc. drawdown is 47.64%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-48.21%Aug 3, 2021111Jan 7, 2022316Apr 13, 2023427
-47.64%May 16, 2024152Dec 20, 2024
-37.34%Aug 1, 202364Oct 30, 202326Dec 6, 202390
-20.23%Feb 28, 202412Mar 14, 202434May 2, 202446
-13.18%Dec 28, 20234Jan 3, 20243Jan 8, 20247

Volatility

Volatility Chart

The current RxSight, Inc. volatility is 18.42%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
18.42%
3.79%
RXST (RxSight, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of RxSight, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for RxSight, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab